Jane Street’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-36,284
| Closed | -$149K | – | 11488 |
|
|
2022
Q1 | $149K | Buy |
36,284
+3,535
| +11% | +$12.8K | ﹤0.01% | 9237 |
|
|
2021
Q4 | $117K | Buy |
+32,749
| New | +$115K | ﹤0.01% | 9160 |
|
|
2021
Q2 | – | Sell |
-21,799
| Closed | -$90K | – | 10740 |
|
|
2021
Q1 | $90K | Buy |
21,799
+8,694
| +66% | +$37.7K | ﹤0.01% | 8680 |
|
|
2020
Q4 | $52K | Buy |
+13,105
| New | +$42.4K | ﹤0.01% | 7314 |
|
|
2020
Q3 | – | Sell |
-22,801
| Closed | -$62K | – | 8244 |
|
|
2020
Q2 | $62K | Buy |
+22,801
| New | +$63.6K | ﹤0.01% | 6826 |
|
|
2019
Q3 | – | Sell |
-110,029
| Closed | -$362K | – | 6003 |
|
|
2019
Q2 | $362K | Buy |
+110,029
| New | +$318K | ﹤0.01% | 3976 |
|
|
2018
Q1 | – | Sell |
-26,569
| Closed | -$53K | – | 5632 |
|
|
2017
Q4 | $53K | Buy |
+26,569
| New | +$57.8K | ﹤0.01% | 4422 |
|
|
2016
Q4 | – | Sell |
-11,254
| Closed | -$19K | – | 4789 |
|
|
2016
Q3 | $19K | Sell |
11,254
-115,220
| -91% | -$141K | ﹤0.01% | 3913 |
|
|
2016
Q2 | $133K | Buy |
+126,474
| New | +$122K | ﹤0.01% | 3852 |
|
|
2015
Q3 | – | Sell |
-14,791
| Closed | -$31K | – | 4328 |
|
|
2015
Q2 | $31K | Buy |
+14,791
| New | +$35.9K | ﹤0.01% | 3542 |
|
|
2014
Q4 | – | Sell |
-53,668
| Closed | -$98K | – | 3190 |
|
|
2014
Q3 | $98K | Buy |
+53,668
| New | +$117K | ﹤0.01% | 2362 |
|
|
2013
Q4 | – | Sell |
-21,006
| Closed | -$85K | – | 3047 |
|
|
2013
Q3 | $85K | Sell |
21,006
-7,938
| -27% | -$34.7K | ﹤0.01% | 2561 |
|
|
2013
Q2 | $120K | Buy |
+28,944
| New | +$112K | ﹤0.01% | 2396 |
|
Other funds holding ATRS
Jane Street's ATRS Position: Q2 2022 in Review
Jane Street sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 36,284 shares — an estimated $149K sold.
Jane Street first reported a position in ATRS in Q2 2013 and held it in 13 quarters. The position peaked at $362K in Q2 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Jane Street reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Jane Street sold 36,284 Antares Pharma, Inc. shares in Q2 2022, an estimated $149K.
- Jane Street first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 13 quarters.
- Jane Street's Antares Pharma, Inc. position peaked at $362K in Q2 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.